MA56118A - Vaccin vivant liquide stabilisé - Google Patents
Vaccin vivant liquide stabiliséInfo
- Publication number
- MA56118A MA56118A MA056118A MA56118A MA56118A MA 56118 A MA56118 A MA 56118A MA 056118 A MA056118 A MA 056118A MA 56118 A MA56118 A MA 56118A MA 56118 A MA56118 A MA 56118A
- Authority
- MA
- Morocco
- Prior art keywords
- liquid vaccine
- live liquid
- stabilized live
- stabilized
- vaccine
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962859491P | 2019-06-10 | 2019-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56118A true MA56118A (fr) | 2022-04-13 |
Family
ID=71895188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056118A MA56118A (fr) | 2019-06-10 | 2020-06-05 | Vaccin vivant liquide stabilisé |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11813322B2 (fr) |
| EP (1) | EP3980058A1 (fr) |
| MA (1) | MA56118A (fr) |
| WO (1) | WO2020251843A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024228212A1 (fr) * | 2023-05-01 | 2024-11-07 | Biovet Private Limited | Formulations de bio-lumpivaxin et leur procédé de préparation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT71926B (en) | 1979-10-29 | 1982-03-31 | Merck & Co Inc | Process for preparing a liquid vaccine comprising a stabilizer |
| RU2643929C2 (ru) * | 2012-04-23 | 2018-02-06 | Бхарат Байотек Интернэшнл Лимитед | Новые ротавирусные вакцинные композиции и способ получения вышеуказанных композиций |
| AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
-
2020
- 2020-06-05 WO PCT/US2020/036272 patent/WO2020251843A1/fr not_active Ceased
- 2020-06-05 MA MA056118A patent/MA56118A/fr unknown
- 2020-06-05 US US16/893,706 patent/US11813322B2/en active Active
- 2020-06-05 EP EP20750016.6A patent/EP3980058A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020251843A1 (fr) | 2020-12-17 |
| US11813322B2 (en) | 2023-11-14 |
| EP3980058A1 (fr) | 2022-04-13 |
| US20200384101A1 (en) | 2020-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4045480A4 (fr) | Formulations pharmaceutiques | |
| MA46766A (fr) | Vaccin antigrippal | |
| EP3580565A4 (fr) | Dosage utilisant différentes hauteurs d'espacement | |
| EP3668541A4 (fr) | Formulations de vaccin pneumococcique conjugué | |
| HRP20251619T1 (hr) | Formulacije pneumokoknih konjugiranih cjepiva | |
| EP4233846C0 (fr) | Formulations pharmaceutiques | |
| EP3603619A4 (fr) | Formulation d'adjuvant vaccinal | |
| MA53543A (fr) | Vaccins peptidiques | |
| IL285674A (en) | Pharmaceutical formulations | |
| DK3886820T3 (da) | Kapselformuleringer | |
| EP3746080A4 (fr) | Formulations pharmaceutiques | |
| DK3709970T3 (da) | Linezolidformuleringer | |
| EP3344293A4 (fr) | Compositions de vaccin stabilisés de vlp | |
| DK3307239T3 (da) | Formuleringer til indgivelse af RSV- og norovirusantigener i tyndtarmen | |
| DK3280447T3 (da) | Farmaceutiske formuleringer | |
| DK3762009T3 (da) | Toxin-afledte indgivelseskonstrukter til oral indgivelse | |
| DK4027973T3 (da) | Formuleringer til lægemiddeladministration | |
| DK3247394T3 (da) | Farmaceutisk formulering omfattende anti-egfr-antistof | |
| DK3706710T3 (da) | Formuleringer med forlænget frigivelse til intraartikulære anvendelser | |
| MA56118A (fr) | Vaccin vivant liquide stabilisé | |
| IT201700038005A1 (it) | Dispositivo per la somministrazione di sostanze | |
| EP3866847A4 (fr) | Vaccin antiviral | |
| PL3787596T3 (pl) | Ulepszone formulacje farmaceutyczne | |
| EP3651800C0 (fr) | Formulations pharmaceutiques hydrocompressées | |
| EP3697393A4 (fr) | Formes posologiques pharmaceutiques |